Oruka Therapeutics (ORKA) PT Raised to $109 at Leerink Partners

March 26, 2026 6:23 AM

Leerink Partners analyst David Risinger raised the price target on Oruka Therapeutics (NASDAQ: ORKA) to $109.00 (from $86.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found